Does therapy with biological drugs influence COVID ‐19 infection? Observational monocentric prevalence study on the clinical and epidemiological data of psoriatic patients treated with biological drugs or with topical drugs alone-Reference-Cited by-同舟云学术

Does therapy with biological drugs influence COVID ‐19 infection? Observational monocentric prevalence study on the clinical and epidemiological data of psoriatic patients treated with biological drugs or with topical drugs alone

Published:2020-11 Issue:6 Volume:33 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Brazzelli Valeria¹^ORCID,Isoletta Eugenio¹,Barak Oren¹,Barruscotti Stefania¹,Vassallo Camilla¹,Giorgini Chiara¹,Michelerio Andrea¹,Tomasini Carlo Francesco¹,Musella Valeria²,Klersy Catherine²

Affiliation:

1. Institute of Dermatology IRCCS Policlinico San Matteo Foundation and University of Pavia Pavia Italy

2. Unit of Clinical Epidemiology and Biometrics, Scientific Direction IRCCS Policlinico San Matteo Foundation Pavia Italy

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.14516

Reference15 articles.

1. RiccardoF AndrianouX BellaA et al. Epidemia COVID‐19. Aggiornamento nazionale 30 giugno 2020 Istituto Superiore di Sanità (ISS) Roma 30 giugno;2020:1‐37.

2. Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic

3. COVID‐19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action

4. Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19

5. Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors influencing the outcomes of dermatoses during the COVID-19 outbreak in China: a retrospective study;Frontiers in Medicine;2024-05-30

2. Psoriasis and biological drugs at the time of SARS-CoV-2 infection: a mini review outlining risk of infection, seroprevalence, and safety and efficacy of the BNT162b2 vaccine;Frontiers in Immunology;2024-01-30

3. The Characteristics of COVID-19 Symptoms and Skin Manifestations among Nonhospitalized COVID-19 Patients with Psoriasis during the Omicron Pandemic in China: A Single-Center Survey-Based Study;Dermatologic Therapy;2023-12-26

4. Biologics and Biosimilars in Psoriasis;Indian Journal of Dermatology;2023-05

5. Prevalence, risk and severity of SARS-CoV-2 infections in psoriasis patients receiving conventional systemic, biologic or topical treatment during the COVID-19 pandemic: a cross-sectional cohort study (PsoCOVID);Journal of Dermatological Treatment;2023-01-16